Published in N Engl J Med on May 09, 2013
Platelet transfusion in hematology, oncology and surgery. Dtsch Arztebl Int (2014) 1.26
Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure. Crit Care (2014) 1.09
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood (2016) 1.05
Prophylactic platelet transfusion. N Engl J Med (2013) 1.00
The European Hematology Association Roadmap for European Hematology Research: a consensus document. Haematologica (2016) 0.97
The rise of multiple imputation: a review of the reporting and implementation of the method in medical research. BMC Med Res Methodol (2015) 0.94
Eliminate prophylactic platelet transfusions? N Engl J Med (2013) 0.93
Clinical indications for thrombopoietin and thrombopoietin-receptor agonists. Transfus Med Hemother (2013) 0.92
Haematological cancer: Prophylactic platelet transfusion is frequently not necessary. Nat Rev Clin Oncol (2013) 0.87
Platelet Transfusion and Hemorrhage. Dtsch Arztebl Int (2015) 0.82
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2015) 0.80
Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis. Haematologica (2015) 0.79
Platelet transfusions in cancer patients with hypoproliferative thrombocytopenia in the intensive care unit. Ann Intensive Care (2015) 0.79
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2015) 0.77
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2014) 0.77
Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2015) 0.77
Platelet-mimetic strategies for modulating the wound environment and inflammatory responses. Exp Biol Med (Maywood) (2016) 0.77
Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2014) 0.76
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2014) 0.76
Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2016) 0.76
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2015) 0.76
Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study. BMJ Open (2016) 0.75
Transfusion medicine as of 2014. F1000Prime Rep (2014) 0.75
Quality Assessment of Established and Emerging Blood Components for Transfusion. J Blood Transfus (2016) 0.75
Indications for platelet transfusion in patients with thrombocytopenia. Blood Transfus (2014) 0.75
Intracranial haemorrhage in thrombocytopenic haematology patients--a nested case-control study: the InCiTe study protocol. BMJ Open (2014) 0.75
Flow cytometry and thromboelastography to assess platelet counts and coagulation in patients with haematological malignancies. Blood Transfus (2014) 0.75
Transfusion of platelets, but not of red blood cells, is independently associated with nosocomial infections in the critically ill. Ann Intensive Care (2016) 0.75
Prophylactic platelet transfusion. N Engl J Med (2013) 0.75
Autologous Stem-Cell Transplantation Without Hematopoietic Support for the Treatment of Hematologic Malignancies in Jehovah's Witnesses. J Clin Oncol (2015) 0.75
Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders. Cochrane Database Syst Rev (2016) 0.75
Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party. Blood Transfus (2016) 0.75
Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States. Transfusion (2016) 0.75
Peri-procedural management of bleeding risks in critical care patients: A local audit and national survey. J Intensive Care Soc (2014) 0.75
Reduced platelet transfusions and earlier platelet engraftment using alemtuzumab-based conditioning regimen in allogeneic stem cell transplantation. J Cancer Res Clin Oncol (2016) 0.75
Laboratory predictors of bleeding, and effect of platelet and RBC transfusions on bleeding outcomes, in the PLADO Trial. Blood (2017) 0.75
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med (2006) 6.90
Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med (2011) 6.13
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. N Engl J Med (2015) 4.79
Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet (2011) 3.41
Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion (2008) 2.87
Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust (2004) 2.74
Heteromultimeric Kv1 channels contribute to myogenic control of arterial diameter. Circ Res (2004) 2.60
T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors. Lancet (2005) 2.41
An update of consensus guidelines for warfarin reversal. Med J Aust (2013) 2.41
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood (2007) 2.36
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Clin Oncol (R Coll Radiol) (2004) 2.35
Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med (2008) 2.22
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect Dis (2013) 2.17
Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin Cancer Res (2007) 2.08
The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial. Lancet (2013) 1.82
Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust (2010) 1.78
End-to-end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses. Transfusion (2006) 1.71
Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol (2010) 1.68
Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol (2013) 1.68
Antenatal screening for HIV; are those who refuse testing at higher risk than those who accept testing? J Public Health (Oxf) (2004) 1.68
UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol (2009) 1.64
Transfusing blood safely and appropriately. BMJ (2013) 1.64
Ten-year pattern of red blood cell use in the North of England. Transfusion (2012) 1.59
Pure red-cell aplasia due to parvovirus B19 infection in a patient treated with alemtuzumab. Blood (2003) 1.58
Tissue plasminogen activator -7351C/T enhancer polymorphism is a risk factor for lacunar stroke. Stroke (2004) 1.55
Risk factors for sleep-disordered breathing in pregnancy. Thorax (2013) 1.52
Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage study. Cancer (2014) 1.50
Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics (2004) 1.49
Brief review: Supplementing oxygen through an airway exchange catheter: efficacy, complications, and recommendations. Can J Anaesth (2011) 1.48
Factors affecting red blood cell storage age at the time of transfusion. Transfusion (2013) 1.47
Effects of homeopathic medicines on polysomnographic sleep of young adults with histories of coffee-related insomnia. Sleep Med (2010) 1.46
Rank minimization with a two-step analysis should not replace randomization in clinical trials. J Clin Epidemiol (2012) 1.44
Metabolic activity of the tongue in obstructive sleep apnea. A novel application of FDG positron emission tomography imaging. Am J Respir Crit Care Med (2014) 1.43
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. Blood (2008) 1.42
The difficult airway with recommendations for management--part 2--the anticipated difficult airway. Can J Anaesth (2013) 1.42
Sleep duration versus sleep insufficiency as predictors of cardiometabolic health outcomes. Sleep Med (2012) 1.40
Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood (2002) 1.39
Immunoplatelet counting: potential for reducing the use of platelet transfusions through more accurate platelet counting. Br J Haematol (2003) 1.39
Mannose-binding lectin deficiency does not increase the prevalence of Helicobacter pylori seropositivity. Eur J Gastroenterol Hepatol (2007) 1.38
Sleep symptoms, race/ethnicity, and socioeconomic position. J Clin Sleep Med (2013) 1.38
Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia. Mol Ther (2013) 1.33
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood (2010) 1.33
Clinical controversies: etomidate as an induction agent for endotracheal intubation in patients with sepsis: continue to use etomidate for intubation of patients with septic shock. Ann Emerg Med (2008) 1.30
Dysfunctional assumptions in bipolar disorder. J Affect Disord (2004) 1.30
Tissue Doppler E/E' ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy. Eur Heart J (2009) 1.30
Concepts of blood transfusion in adults. Lancet (2013) 1.28
Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force. Br J Haematol (2010) 1.28
Dietary nutrients associated with short and long sleep duration. Data from a nationally representative sample. Appetite (2013) 1.24
The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. Blood (2002) 1.21
The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab. Br J Haematol (2010) 1.20
Guidelines for supportive care in multiple myeloma 2011. Br J Haematol (2011) 1.19
The comprehensiveness care of sickle cell disease. Eur J Haematol (2002) 1.19
Reliability of a single objective measure in assessing sleepiness. Sleep (2012) 1.17
Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group. Sleep (2013) 1.16
Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. J Rheumatol (2004) 1.15
Age of red blood cells and mortality in the critically ill. Crit Care (2011) 1.15
Perceived racial discrimination as an independent predictor of sleep disturbance and daytime fatigue. Behav Sleep Med (2012) 1.14
Prevalence of maternal anaemia and its predictors: a multi-centre study. Eur J Obstet Gynecol Reprod Biol (2011) 1.14
Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation. Stem Cells (2009) 1.14
Investigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma. BMC Cancer (2005) 1.12
MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival. Biol Direct (2011) 1.10
The difficult airway with recommendations for management--part 1--difficult tracheal intubation encountered in an unconscious/induced patient. Can J Anaesth (2013) 1.08
Quantitative airway analysis during drug-induced sleep endoscopy for evaluation of sleep apnea. Laryngoscope (2012) 1.07
Sleep symptoms associated with intake of specific dietary nutrients. J Sleep Res (2013) 1.06
European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Br J Haematol (2003) 1.05
Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006. Transfusion (2007) 1.05
Red cell transfusion for the management of upper gastrointestinal haemorrhage. Cochrane Database Syst Rev (2010) 1.05
High potency cannabis: the forgotten variable. Addiction (2005) 1.05
The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer. Clin Cancer Res (2013) 1.04
New strategies for the optimal use of platelet transfusions. Hematology Am Soc Hematol Educ Program (2008) 1.04
Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Haematologica (2003) 1.03
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev (2012) 1.03
The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study. Br J Haematol (2006) 1.03
Pathogen-reduced platelets for the prevention of bleeding. Cochrane Database Syst Rev (2013) 1.02
DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA doubling time. Cancer Immunol Immunother (2012) 1.02
Preoperative transfusion in sickle cell disease: a survey of practice in England. Eur J Haematol (2005) 1.01
Enzyme replacement therapy "drug holiday": results from an unexpected shortage of an orphan drug supply in Australia. Blood Cells Mol Dis (2010) 1.01
Anaemia of cancer: impact on patient fatigue and long-term outcome. Oncology (2005) 1.00
Mitral valve repair with aortic valve replacement is superior to double valve replacement. J Thorac Cardiovasc Surg (2003) 1.00
Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases. Haematologica (2006) 0.99
Guidelines for the diagnosis and management of adult myelodysplastic syndromes. Br J Haematol (2013) 0.99
What is the maximum time that a unit of red blood cells can be safely left out of controlled temperature storage? Transfus Med Rev (2011) 0.99
BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration. Cancer Genet Cytogenet (2002) 0.98
Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica (2014) 0.97
New directions in the genomics of allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2007) 0.97
Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells. J Biol Chem (2013) 0.95
Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics (2009) 0.95
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trial. Transfus Med Rev (2013) 0.95